[Concordance of medication prescription records in the hospitalised surgical patient]. / Concordancia de los registros de prescripción de medicamentos en el paciente quirúrgico hospitalizado.

INTRODUCTION: Electronic prescription is the prescription system that allows healthcare professionals to send medication prescriptions directly to community pharmacies and the outpatient unit of Hospital Pharmacy Services for dispensing. However, there is difficulty in obtaining a reliable pharmacotherapeutic history in chronic patients through electronic prescription upon hospital admission as a critical point for adequate treatment adaptation. Therefore, the pharmacist as a member of the multidisciplinary team must ensure, through medication conciliation, an adequate transition of care through the correct management of the treatment that the chronic patient requires during their hospitalization. OBJECTIVES: To evaluate the quality of electronic prescription records for routine chronic treatment by analyzing the concordance of the electronic prescription. MATERIAL AND METHODS: Observational, cross-sectional and retrospective study at the General University Hospital of Elche. Hospitalized patients in charge of the Orthopedic Surgery and Traumatology, Urology and Neurosurgery Services in which the responsible doctor requested medication reconciliation by the Pharmacy Service between January 2022 - December 2022 were included. RESULTS: 378 patients, 209 (55.3%) women and 169 (44.7%) men, with a mean age±standard deviation of 71.0±11.6 years and 69.0±11.8 years, respectively. The total percentage of patients with discrepancies in the electronic prescription with respect to the usual chronic treatment was 60.6%, reflecting that only 39.4% of the patients had non-discordant electronic prescriptions. CONCLUSIONS: More than half of hospitalized surgical patients present discrepancies in the medications prescribed in the home electronic prescription, which justifies the importance of treatment reconciliation upon admission carried out by hospital pharmacists.

Evaluación del grado de adherencia al tratamiento intravenoso no antineoplásico de pacientes ambulatorios / Evaluation of the degree of adherence to non-antineoplastic intravenous treatment of ambulatory patients

Introducción: La falta de adherencia al tratamiento farmacológico es un problema prevalente y relevante en la evolución clínica.Objetivo: Evaluar el grado de adherencia al tratamiento intravenoso no antineoplásico de pacientes crónicos que acuden al hospital de día (HD), identificar los factores relacionados y analizar los desvíos de programación de la cita previa en el HD y su impacto en el Servicio de Farmacia (SF).Material y métodos: Estudio descriptivo longitudinal retrospectivo de tres años de duración (2017-2019) que incluyó a los pacientes que acudieron al HD a administrarse el tratamiento. Los datos de adherencia se extrajeron de los registros del SF y los datos demográficos-clínicos, de las historias clínicas electrónicas. El grado de adherencia se expresó en porcentaje (adherencia adecuada ≥90%). La asociación entre las variables y el grado de adherencia se estudió mediante test estadísticos de contraste de hipótesis.Resultados: Se incluyeron 300 pacientes, 60% mujeres, edad media 47 años. El 18% presentaron una adherencia inadecuada. La adherencia se asoció con la edad, el medicamento administrado, el intervalo posológico y la persistencia al tratamiento (p<0,05). El 5,6% del trabajo de HD se desvió de la programación suponiendo un trabajo adicional para el SF.Conclusiones: El grado de adherencia al tratamiento era inadecuado en casi una cuarta parte de la población. La edad, el medicamento infundido, el intervalo posológico y la persistencia al tratamiento se asociaron con la adherencia de los pacientes. Los desvíos en la programación de HD se tradujeron en trabajo sobreañadido para el SF. (AU)

Introduction: The lack of adherence to pharmacological treatment of patients with chronic diseases it is a relevant problem.Objective: To assess the degree of adherence to the non-chemotherapy intravenous treatment of chronic patients who came to the outpatient clinic (OC), to identify the possible specific factors related to therapeutic compliance and to analyze the appointment changes in the OC and its impact on the Pharmacy Department (PD).Material and methods: Retrospective longitudinal descriptive study of three years duration (2017-2019). This included patients who went to the OC to receive the treatment. Adherence data were extracted from the PD records and demographic-clinical data from the review of electronic health records. Besides, the degree of adherence was expressed as a percentage (adherence adequate ≥90%). The association between the variables studied and the degree of adherence was estimated by means of statistical tests of hypothesis contrast.Results: A total sample size of 300 patients were included, mean age 47 years, 60% women. Adherence of the treatment was inadequate in 18% of patients. The variables that showed a statistically significant association with adherence were the age, the drug delivered, the dosage interval and the persistence of treatment (p<0.05). 5.6% of OC work deviated from schedule and it meant additional work to the PD.Conclusions: The degree of adherence to the intravenous ambulatory treatment was inadequate in approximately a quarter of the population. The age, the infused drug, the dosage interval and the persistence of treatment were the variables that showed association with the adherence. Changes to OC programming resulted in over-added work for the PD. (AU)

A rapid validated UV-HPLC method for the simultaneous determination of the antiretroviral compounds darunavir and raltegravir in their dosage form.

OBJECTIVE: A rapid, simple and sensitive high-performance liquid chromatography (HPLC) method with ultraviolet detection has been developed for quantification of darunavir and raltegravir in their pharmaceutical dosage form. METHODS: The assay enables the measurement of both drugs with a linear calibration curve (R2= 0.999) over the concentration range 5-100 mg/L. The determination was performed on an analytical Tracer Excel 120 ODSB (15x0.4.6 cm) column at 35ºC. The selected wavelength was 254 nm. The mobile phase was a mixture of 0.037 M sodium dihydrogen phosphate buffer, acetonitrile and methanol (40:50:10, v/v/v) at a flow rate of 2.0 mL/min Nevirapine (50 mg/L) was used as internal standard. RESULTS: Accuracy, intra-day repeatability (n = 5), and inter-day precision (n = 3) were found to be satisfactory, being the accuracy from -4.33 to 3.88% and precisions were intra-day and inter-day, 0.25% and 4.42% respectively in case of darunavir. Raltegravir intra-day and inter-day precisions lower of 1.01 and 2.36%, respectively and accuracy values bet from -4.02 to 1.06%. CONCLUSIONS: Determination of the darunavir and raltegravir in their dosage form was done with a maximum deviation of 4%. This analytical method is rapid, easily implantable and offers good results.

Sacral nerve stimulation in the treatment of severe faecal incontinence: long-term clinical, manometric and quality of life results.

BACKGROUND: Faecal incontinence (FI) is a complex and multifactorial health problem. Treatment has to be individualised, analysing the aetiology and gravity in every case. Sacral nerve stimulation (SNS) has been shown to effectively improve treatment of FI. METHODS: Fifty patients with severe FI treated with SNS between March 2002 and December 2010 were analysed. Preoperative assessment included physical examination, anorectal manometry and anal endosonography. Anal continence was evaluated using the Wexner continence grading system. Quality of life was evaluated using the Fecal Incontinence Quality of life Scale (FIQLS). Follow-up appointments were scheduled at 1, 6 and 12 months and annually thereafter. Wexner score, FIQLS and the ability to defer defecation were assessed at each visit. RESULTS: Fifty patients underwent a permanent implant. The overall mean follow-up period was 55.52 ± 31.84 months. After 6 months, SNS significantly improved FI and positively impacted quality of life, as evidence by significant improvements in all 4 scales of the FIQLS. Anorectal manometry showed a trend towards an increase in maximum resting pressure and maximum pressure. After the first assessment at 6 months, Wexner score and FIQLS remained stable. Ability to defer defecation was also maintained. During follow-up, 3 patients (6 %) experienced implant site pain and episodes of extremity pain and paresthesias that were refractory to medical management and required device explantation. The implant site infection rate was 2 %. CONCLUSIONS: Analysis of our long-term results confirms the safety and effectiveness of SNS in the management of patients with FI.

Applicability, safety and efficiency of outpatient treatment in uncomplicated diverticulitis.

BACKGROUND: In most cases of diverticulitis, inflammation is mild, and the only treatment required is a clear liquid diet and antibiotics. Until recently, patients were given this treatment as inpatients with the consequent expenditure of resources. The aim of this study was to assess the safety and efficacy of an outpatient treatment protocol with oral antibiotics in selected patients with uncomplicated acute diverticulitis in comparison with inpatient intravenous treatment. METHODS: We conducted a prospective non-randomized study between January 2007 and December 2009. We included all patients diagnosed with uncomplicated acute diverticulitis, at the Emergency Department of the University General Hospital of Elche. We compared the efficacy, safety and costs of hospital treatment with intravenous antibiotics and outpatient treatment with oral antibiotics. Seventy-six patients were included in the study. Forty-four of them underwent intravenous treatment with Metronidazole 500 mg/8 h + Ciprofloxacin 400 mg/12 h (hospital treatment group) and 32 took oral antibiotics Metronidazole 500 mg/8 h and Ciprofloxacin 500 mg/12 h (outpatient group). RESULTS: Outpatient treatment is viable in almost 95 % of those patients suffering from uncomplicated acute diverticulitis. Treatment was effective in resolving inflammation, and there were no complications in the majority of cases (94 %). Only 2 patients (6 %) required admission after outpatient treatment. The results further reflect complications and relapse rates similar to those of patients admitted to hospital and treated with intravenous antibiotics. There are no significant statistical differences (p = 0.86) between inpatients and outpatients. It is possible to save approximately 1,600 € per patient with outpatient treatment (p < 0.05). CONCLUSIONS: Outpatient treatment has demonstrated a safety and efficiency similar to inpatient treatment, producing an important reduction in expenses and medical resources.

Hernia de bochdalek en el anciano. A propóstito de un caso / Bochdalek's hernia in an elderly patient. A Case report

La hernia de Bochdalek es la hernia diafragmática con mayor incidencia. Presentamos el caso de una mujer de 86 años con un cuadro de dolor abdominal, vómitos e insuficiencia respiratoria secundarias a una hernia de Bochdalek gigante (AU)

Bochdalek's hernia is the diaphragmatic hernia with major incidence. We present the case of a 86-year-old woman with a picture of abdominal pain, vomits and respiratory insufficiency secondary to a giant hernia of Bochdalek (AU)